Principles of primary prevention of cardiovascular diseases in patients with cancer. Expert Opinion of the Working Group on Prevention and Epidemiology (Cardio-oncology Task Force) and the Working Group on Cardio-oncology of the Polish Cardiac Societ

Despite spectacular progress in the treatment of patients diagnosed with cancer, cardiovascular diseases are the second leading cause of death in cancer patients, after cancer itself. According to the CONNECT-POL registry, cardiovascular risk factors are very often detected in cancer patients even before starting oncological treatment. The rapidly expanding range of new life-saving cancer therapies is unfortunately characterized by a wide range of both early and late cardiovascular complications. These include not only the classic complications long described as heart failure, but also hypertension, dyslipidemia, diabetes, and accelerated atherosclerosis. Preventive strategies aimed at their prevention and optimal treatment are crucial for improving both oncological and cardiological prognosis. Unfortunately, as is widely known, the presence of cancer negatively impacts the quality and intensity of preventive measures. In our expert opinion, after a cancer diagnosis, in addition to promptly initiating oncological therapy, prevention or addressing existing cardiovascular risk factors is also of great importance for the patient's further treatment and prognosis. This should generally be done in accordance with the principles adopted for the general population, but with certain differences for cancer patients, especially if this is a group of patients with advanced cancer. It is crucial that these activities are not conducted solely by cardiologists, but also with the support of primary care physicians and other specialties, including oncologists, with the full cooperation and acceptance of the patient. According to the authors of this document, there is a need to emphasize the role of primary prevention of cardiovascular disease in cancer patients, which has been neglected until now, and our expert opinion summarizes these recommendations.

Authors

Institutions

Publication Details

Journal
Kardiologia Polska
Published
2025-10-23
DOI
https://doi.org/10.33963/v.phj.109247
Primary Topic
Chemotherapy-induced cardiotoxicity and mitigation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Principles of primary prevention of cardiovascular diseases in patients with cancer. Expert Opinion of the Working Group on Prevention and Epidemiology (Cardio-oncology Task Force) and the Working Group on Cardio-oncology of the Polish Cardiac Societ

Stanisław Surma, Przemysław Leszek, Ewa Lewicka, Piotr Gościniak et al.
Kardiologia Polska
Chemotherapy-induced cardiotoxicity and mitigation
article

Principles of primary prevention of cardiovascular diseases in patients with cancer. Expert Opinion of the Working Group on Prevention and Epidemiology (Cardio-oncology Task Force) and the Working Group on Cardio-oncology of the Polish Cardiac Societ

Stanisław Surma, Przemysław Leszek, Ewa Lewicka, Piotr Gościniak, Agata Bielecka‐Dąbrowa, Jarosław Dróżdż, Daniel Śliż, Grzegorz Piotrowski, Maciej Dyrbuś, Katarzyna Styczkiewicz, Joanna Kufel-Grabowska, Renata Główczyńska, Alicja Baska, Mateusz Tajstra, Maciej Banach
article en

Abstract

Despite spectacular progress in the treatment of patients diagnosed with cancer, cardiovascular diseases are the second leading cause of death in cancer patients, after cancer itself. According to the CONNECT-POL registry, cardiovascular risk factors are very often detected in cancer patients even before starting oncological treatment. The rapidly expanding range of new life-saving cancer therapies is unfortunately characterized by a wide range of both early and late cardiovascular complications. These include not only the classic complications long described as heart failure, but also hypertension, dyslipidemia, diabetes, and accelerated atherosclerosis. Preventive strategies aimed at their prevention and optimal treatment are crucial for improving both oncological and cardiological prognosis. Unfortunately, as is widely known, the presence of cancer negatively impacts the quality and intensity of preventive measures. In our expert opinion, after a cancer diagnosis, in addition to promptly initiating oncological therapy, prevention or addressing existing cardiovascular risk factors is also of great importance for the patient's further treatment and prognosis. This should generally be done in accordance with the principles adopted for the general population, but with certain differences for cancer patients, especially if this is a group of patients with advanced cancer. It is crucial that these activities are not conducted solely by cardiologists, but also with the support of primary care physicians and other specialties, including oncologists, with the full cooperation and acceptance of the patient. According to the authors of this document, there is a need to emphasize the role of primary prevention of cardiovascular disease in cancer patients, which has been neglected until now, and our expert opinion summarizes these recommendations.

Kardiologia PolskaVol. 84(1)
Rzeszów University of Technology (PL), Johns Hopkins University (US), Medical University of Silesia (PL), Medical University of Warsaw (PL), Johns Hopkins Medicine (US), Memorial Hospital (US), Medical University of Lodz (PL), Silesian Center for Heart Disease (PL), Postgraduate School of Molecular Medicine (PL), Central Clinical Hospital (PL), Polish Mother’s Memorial Hospital Research Institute (PL), Specjalistyczny Szpital Miejski im. M. Kopernika (PL), Cardinal Stefan Wyszynski University in Warsaw (PL), Gdańsk Medical University (PL), Pomeranian Medical University (PL), University of Rzeszów (PL)
Openalex Percentile: Top 54%
Chemotherapy-induced cardiotoxicity and mitigation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.